Recent Federal Actions Put US, Massachusetts Biotech Leadership at Risk: MassBio
MassBio’s new report outlines several concerns, including NIH cuts undermining the research engine, FDA reductions delaying innovation and trade barriers disrupting supply chains.
Recent Federal Actions Put US, Massachusetts Biotech Leadership at Risk: MassBio Read More »
